Introduction:
Colonoscopy is the most frequently performed endoscopic procedure in the United States. It is the mainstay of diagnostic and therapeutic options for the practicing gastroenterologist. It plays a fundamental role in colorectal cancer (CRC) prevention, with a dominant position among screening options for CRC and precancerous lesions. (1) Over the past decade, there have been significant advances in the field of CRC and colonoscopy, including a better understanding of the importance of right-sided lesions, the sessile serrated pathway, and recognition of the significance of operator dependence in colonoscopy. This has been paralleled by an array of technological and technical advances, which have transformed the field of colonoscopy and improved patient care. This paper addresses the diverse and expanding field of advanced colonoscopy techniques and technologies. It is intended to be a primer on recent and impactful developments in advanced technologies for screening/imaging, mucosal resection techniques, and endoscopic management of CRC (Table 1) .
Table 1
Advanced Colonoscopy Techniques and Technologies 
Accessories:
The use of a transparent cap placed at the distal tip of the colonoscope ("capassisted colonoscopy") has been proposed to improve mucosal visualization by allowing flattening of colonic folds. The effect on polyp detection has not been consistent. (6, 7) A meta-analysis from 2012 that included 16 randomized controlled trials of cap-assisted colonoscopy and nearly 9,000 patients showed a small benefit from the use of the transparent cap, with a relative risk (RR) of identifying polyps of 1.08 (95% CI, 1.00-1.17), although adenoma detection was 4 not significantly increased with cap use.(8) Another meta-analysis showed similar results, with a RR of 1.13. (9) EndoRings (EndoAid Ltd, Caesarea, Israel) is a mucosal detection aid that fits on the distal tip of the colonoscope, composed of a series of sequentially spaced silicone disks that emanate from the distal tip cuff (Figure 1 ).(6, 7) The disks are flexible and engage the mucosa to flatten folds through stretching. They also maintain some traction during loop reduction and during interventions.(10) A multicenter tandem colonoscopy cross-over study (currently in abstract form) of 66 patients showed an adenoma miss rate of 15% in the group receiving EndoRingsassisted colonoscopy (followed by standard colonoscopy) vs. a 48% miss rate in the group receiving standard colonoscopy first (followed by EndoRings-assisted colonoscopy, p < 0.01). (10) The Endocuff (Arc Medical Design Ltd, Leeds, UK) is a cylindrical cuff with thin flexible arms, which is placed at the distal tip of the colonoscope (Figure 2 ).
These projections engage the mucosa on withdrawal and allow for manipulation of folds for close interrogation. Similar to the EndoRings device, they maintain a degree of traction to avoid slipping during reduction and interventions.(6, 7) A multicenter randomized trial of standard colonoscopy vs. Endocuff-assisted colonoscopy showed a higher median number of polyps detected per colonoscopy (1 vs. 2, p = 0.002).(11) Another randomized trial of standard vs. Endocuffassisted colonoscopy included 500 patients at 4 centers in Germany, and reported an ADR of 35% in the Endocuff assisted group compared to 21% in the standard colonoscopy group (p<0.0001).(12) There have not been any major adverse events associated with its use.
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Right-sided mucosal lesions can be missed, due to a propensity for lesions in the right colon to be flat and covered with mucus, the presence of large folds and the slight increased difficulty of maneuvering the colonoscope in the right colon and around the hepatic flexure. "Second-look" examination of the right colon by either forward-viewing or retroflexion can result in increased adenoma detection. (13, 14) A second-look evaluation of the right colon has been demonstrated to identify an additional polyp in 4-10% of cases. (13, 14) The Third Eye Retroscope (Avantis Medical Systems, Inc, Sunnyvale, CA, USA) is a through-the-scope retrograde viewing system composed of an LED light source and camera, which was developed to allow the examination of proximal aspects of folds without the need for retroflexion. One nonrandomized study showed a 15% increase in polyp detection and 16% increase in adenoma detection rate among 298 subjects. (14) A randomized back-to-back study of 349 subjects showed 23% additional adenomas detected on repeat colonoscopy (standard colonoscopy then Third-eye assisted colonoscopy) compared to standard colonoscopy alone. (15) The device has limitations, including cost, decreased ability to suction, and need to remove the device to insert polypectomy tools. To mitigate some of these limitations, the manufacturer is developing a panoramic camera (330 degree visualization) that attaches to the distal tip of the colonoscope. It requires a separate video processing unit. Preliminary feasibility data have described its use in a small number of patients, and the device has recently received FDA clearance. (16) The NaviAid G-EYE system (Smart Medical Systems Ltd, Ra'anana, Israel) is a system that has a balloon integrated permanently into the distal portion of the colonoscope shaft. The balloon is deflated during insertion, but can be inflated at varying pressures via a foot-pedal control system to assist in minimizing folds 
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Dye-based chromocolonoscopy, however, is associated with improved dysplasia detection compared to the traditional approach. One study compared targeted biopsies for surveillance with white light and chromocolonoscopy, (57) and found that chromocolonoscopy detected dysplasia in 8% of cases, while standard colonoscopy detected dysplasia in only 1.6% of cases. (57) A prospective tandem colonoscopy study of 75 patients showed significantly more dysplasia in the chromocolonoscopy group compared to the high definition white light group (21% vs. 9%, respectively; p= 0.007). (58) Opportunities in development and research abound, including strategies to decrease operator dependence, continued development of techniques and technologies to accurately detect and diagnose polyps and optimize the management of colorectal neoplasia, and measurement of the impact of these advances on CRC prevention.
